Biotech

All Articles

Basilea credit ratings $268M BARDA funding for antifungals, anti-biotics

.Basilea Pharmaceutica's work cultivating brand new antifungals has received a significant increase ...

Capricor markets Europe rights to late-stage DMD therapy for $35M

.Possessing already gathered up the U.S. rights to Capricor Rehabs' late-stage Duchenne muscular dys...

FDA scraps adcomm for Applied's rare ailment drug

.After pushing the choice meeting for Applied Therapeutics' metabolic ailment medication govorestat,...

Novo inks $600M NanoVation package to analyze hereditary medications ex-liver

.Novo Nordisk is actually continuing its own push into genetic medications, accepting compensate Nan...

Innovent links cytokine to colorectal cancer cells reactions

.Innovent Biologics has created the case that its checkpoint inhibitor-cytokine combination protein ...

Merck, Daiichi ADC strikes target in period 3 bronchi cancer cells research

.A stage 3 trial of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina strengthens artificial intelligence focus with collab to choose cancer targets

.5 months after Rakovina Therapeutics rotated toward expert system, the cancer-focused biotech has s...

Ascendis' dwarfism medication favorites in phase 3, threatens BioMarin

.Ascendis Pharma has actually become a prospective threat to BioMarin's Voxzogo, stating phase 3 dev...

Despite ph. 3 miss out on, Alkeus sees pathway ahead of time for eye health condition asset

.Though Alkeus Pharmaceuticals' oral eye condition resource failed to substantially reduce geographi...

Kairos goes public along with $6M IPO to money trials of cancer cells drug

.With a triad of biotechs striking the Nasdaq on Friday, it was actually very easy to overlook a sma...